Table 3.

Race-specific standardized incidence ratios for selected cancers among a cohort of patients with systemic lupus erythematosus (SLE), California. 1991–2002 (n = 30,478)^a

Race	Observed	Expected	SIR	95% Cl
Breast
Non-Hispanic white	165	230.6	0.72	0.61–0.83
Non-Hispanic black	31	35.8	0.87	0.58–1.23
Hispanic	31	27.1	1.15	0.79–1.63
Non-Hispanic Asian/Pacific Islander Lung	8	9.7	0.83	0.36–1.63
Non-Hispanic white	176	105.4	1.67	1.43–1.94
Non-Hispanic black	22	15.0	1.47	0.92–2.23
Hispanic	14	6.7	2.09	1.17–3.58
Non-Hispanic Asian/Pacific Islander	5	2.9	1.72	0.56–4.02
Kidney
Non-Hispanic white	19	12.7	1.50	0.90–2.34
Non-Hispanic black	9	2.1	4.29	1.93–8.04
Hispanic	8	2.3	3.48	1.53–7.00
Non-Hispanic Asian/Pacific Islander		0.4	2.50	0.62–14.02
NHL
Non-Hispanic white	59	25.5	2.31	1.76–2.98
Non-Hispanic black	7	3.0	2.33	0.93–4.75
Hispanic	22	3.6	6.11	3.80–9.18
Non-Hispanic Asian/Pacific Islander	8	1.1	7.27	3.08–14.07
Vagina/Vulva
Non-Hispanic white	19	9.7	1.96	1.19–3.07
Non-Hispanic black	6	1.7	3.53	1.33–7.87
Hispanic	19	1.3	14.62	8.93–23.15
Non-Hispanic Asian/Pacific Islander	4	.02	20.00	4.83–45.35

^aSIR = standardized incidence ratio; CI = confidence interval